# FC Patch Low: Metabolism Study

> **NCT00933179** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 30 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Gestodene/EE Patch (BAY86-5016)
- **DRUG:** EE/Levonorgestrel (Microgynon, BAY86-4977)

## Key facts

- **NCT ID:** NCT00933179
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933179, "FC Patch Low: Metabolism Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00933179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*